MicroRNAs in renal cell carcinoma: A systematic review of clinical implications (Review)
- Authors:
- Ming Li
- Ying Wang
- Yongsheng Song
- Renge Bu
- Bo Yin
- Xiang Fei
- Qizhen Guo
- Bin Wu
-
Affiliations: Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Nuclear Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China - Published online on: February 13, 2015 https://doi.org/10.3892/or.2015.3799
- Pages: 1571-1578
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
This article is mentioned in:
Abstract
 |
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cohen HT and McGovern FJ: Renal-cell carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Rini BI, Rathmell WK and Godley P: Renal cell carcinoma. Curr Opin Oncol. 20:300–306. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Janzen NK, Kim HL, Figlin RA and Belldegrun AS: Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 30:843–852. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Bullock A, McDermott DF and Atkins MB: Management of metastatic renal cell carcinoma in patients with poor prognosis. Cancer Manag Res. 2:123–132. 2010.PubMed/NCBI | |
|
Lilleby W and Fossa SD: Chemotherapy in metastatic renal cell cancer. World J Urol. 23:175–179. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Redova M, Svoboda M and Slaby O: MicroRNAs and their target gene networks in renal cell carcinoma. Biochem Biophys Res Commun. 405:153–156. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Rodriguez A, Griffiths-Jones S, Ashurst JL and Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Saini HK, Griffiths-Jones S and Enright AJ: Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci USA. 104:17719–17724. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cai X, Hagedorn CH and Cullen BR: Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA. 10:1957–1966. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lee Y, Kim M, Han J, et al: MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Denli AM, Tops BB, Plasterk RH, Ketting RF and Hannon GJ: Processing of primary microRNAs by the microprocessor complex. Nature. 432:231–235. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Han J, Lee Y, Yeom KH, Kim YK, Jin H and Kim VN: The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 18:3016–3027. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lund E, Guttinger S, Calado A, Dahlberg JE and Kutay U: Nuclear export of microRNA precursors. Science. 303:95–98. 2004. View Article : Google Scholar | |
|
Yi R, Qin Y, Macara IG and Cullen BR: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17:3011–3016. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12. 2007. View Article : Google Scholar | |
|
Jackson RJ and Standart N: How do microRNAs regulate gene expression? Sci STKE. Jan 2–2007.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI | |
|
Nilsen TW: Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet. 23:243–249. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Pillai RS, Bhattacharyya SN and Filipowicz W: Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kawakami K, Enokida H, Chiyomaru T, et al: The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer. 48:827–836. 2012. View Article : Google Scholar | |
|
Huang J, Yao X, Zhang J, et al: Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma. Cancer Sci. 104:1609–1617. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yu H, Lin X, Wang F, et al: Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells. Oncol Lett. 7:799–804. 2014.PubMed/NCBI | |
|
Yamamura S, Saini S, Majid S, et al: MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis. 33:294–300. 2012. View Article : Google Scholar : | |
|
Zhang C, Mo R, Yin B, Zhou L, Liu Y and Fan J: Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma. Oncol Lett. 7:1689–1694. 2014.PubMed/NCBI | |
|
Cui L, Zhou H, Zhao H, et al: MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC Cancer. 12:5462012. View Article : Google Scholar : PubMed/NCBI | |
|
Wu D, Pan H, Zhou Y, Zhou J, Fan Y and Qu P: microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma. Mol Med Rep. 9:2491–2498. 2014.PubMed/NCBI | |
|
Yamada Y, Hidaka H, Seki N, et al: Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. Cancer Sci. 104:304–312. 2013. View Article : Google Scholar | |
|
Yamasaki T, Seki N, Yamada Y, et al: Tumor suppressive microRNA138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Int J Oncol. 41:805–817. 2012.PubMed/NCBI | |
|
Song T, Zhang X, Wang C, et al: MiR-138 suppresses expression of hypoxia-inducible factor 1α (HIF-1α) in clear cell renal cell carcinoma 786-O cells. Asian Pac J Cancer Prev. 12:1307–1311. 2011. | |
|
Liang J, Zhang Y, Jiang G, et al: MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is down-regulated in human clear cell renal cell carcinoma. Oncol Res. 21:83–91. 2013. View Article : Google Scholar | |
|
Yu XY, Zhang Z, Liu J, Zhan B and Kong CZ: MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B. Onco Targets Ther. 6:349–354. 2013.PubMed/NCBI | |
|
Chen X, Wang X, Ruan A, et al: miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Clin Cancer Res. 20:2617–2630. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yoshino H, Enokida H, Itesako T, et al: Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma. Cancer Sci. 104:1567–1574. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Doberstein K, Steinmeyer N, Hartmetz AK, et al: MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. Neoplasia. 15:218–230. 2013.PubMed/NCBI | |
|
Lu R, Ji Z, Li X, et al: miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. J Cancer Res Clin Oncol. 140:387–397. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Xu X, Wu J, Li S, et al: Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. Mol Cancer. 13:1092014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao J, Lei T, Xu C, et al: MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3. Biochem Biophys Res Commun. 438:439–444. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Khella HW, Bakhet M, Allo G, et al: miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis. 34:2231–2239. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Dong B, Zhang J, et al: miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma. Tumour Biol. 35:5833–5843. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Chen X, Wang R, et al: microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Oncol Rep. 30:643–650. 2013.PubMed/NCBI | |
|
Majid S, Saini S, Dar AA, et al: MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res. 71:2611–2621. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Zhao J, Zhang JW, et al: MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration. Neoplasma. 60:511–515. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yamasaki T, Seki N, Yoshino H, et al: MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. J Urol. 190:1059–1068. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhai Q, Zhou L, Zhao C, et al: Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochem Biophys Res Commun. 419:621–626. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang WB, Pan ZQ, Yang QS and Zheng XM: Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma. Ir J Med Sci. 182:621–627. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ueno K, Hirata H, Shahryari V, et al: Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer. 104:308–315. 2011. View Article : Google Scholar : | |
|
Saini S, Yamamura S, Majid S, et al: MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res. 71:6208–6219. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hidaka H, Seki N, Yoshino H, et al: Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget. 3:44–57. 2012.PubMed/NCBI | |
|
Yamasaki T, Seki N, Yoshino H, et al: Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma. Cancer Sci. 104:1411–1419. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hirata H, Hinoda Y, Ueno K, Nakajima K, Ishii N and Dahiya R: MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer. Carcinogenesis. 33:501–508. 2012. View Article : Google Scholar : | |
|
Yu Z, Ni L, Chen D, et al: Identification of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Xin S, He Z, et al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma. Cell Physiol Biochem. 33:1631–1642. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lv L, Huang F, Mao H, et al: MicroRNA-21 is overexpressed in renal cell carcinoma. Int J Biol Markers. 28:201–207. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Dey N, Das F, Ghosh-Choudhury N, et al: microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. PLoS One. 7:e373662012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang A, Liu Y, Shen Y, Xu Y and Li X: miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma. Urology. 78:e13–e19. 2011. View Article : Google Scholar | |
|
Zaman MS, Thamminana S, Shahryari V, et al: Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One. 7:e502032012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Zabirnyk O, Wang H, et al: miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene. 29:4914–4924. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Chen T, Zhong Z, Wang Y, Li Y and Zhao X: microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Mol Med Rep. 5:949–954. 2012.PubMed/NCBI | |
|
Nakada C, Tsukamoto Y, Matsuura K, et al: Overexpression of miR-210, a downstream target of HIF1alpha, causes centrosome amplification in renal carcinoma cells. J Pathol. 224:280–288. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Boguslawska J, Wojcicka A, Piekielko-Witkowska A, Master A and Nauman A: MiR-224 targets the 3′UTR of type 1 5′-iodothy-ronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer. PLoS One. 6:e245412011. View Article : Google Scholar | |
|
Xiao X, Tang C, Xiao S, Fu C and Yu P: Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells. Oncol Res. 20:537–544. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Jung M, Mollenkopf HJ, Grimm C, et al: MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med. 13:3918–3928. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Gottardo F, Liu CG, Ferracin M, et al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng T, Wang L, Li Y, Huang C, Zeng L and Yang J: Differential microRNA expression in renal cell carcinoma. Oncol Lett. 6:769–776. 2013.PubMed/NCBI | |
|
Faragalla H, Youssef YM, Scorilas A, et al: The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J Mol Diagn. 14:385–392. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Silva-Santos RM, Costa-Pinheiro P, Luis A, et al: MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis. Br J Cancer. 109:2646–2653. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wotschofsky Z, Liep J, Meyer HA, et al: Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas. Int J Biol Sci. 8:1363–1374. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Heinzelmann J, Henning B, Sanjmyatav J, et al: Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol. 29:367–373. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Redova M, Poprach A, Nekvindova J, et al: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med. 10:552012. View Article : Google Scholar : PubMed/NCBI | |
|
Teixeira AL, Ferreira M, Silva J, et al: Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients. Tumour Biol. 35:4057–4066. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lichner Z, Mejia-Guerrero S, Ignacak M, et al: Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways. Am J Pathol. 180:1675–1687. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB and Gleadle JM: The VHL-dependent regulation of microRNAs in renal cancer. BMC Med. 8:642010. View Article : Google Scholar : PubMed/NCBI | |
|
Lian JH, Wang WH, Wang JQ, Zhang YH and Li Y: MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway. Asian Pac J Cancer Prev. 14:5017–5021. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bera A, Ghosh-Choudhury N, Dey N, et al: NFkappaB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation. Cell Signal. 25:2575–2586. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bera A, Das F, Ghosh-Choudhury N, Kasinath BS, Abboud HE and Choudhury GG: microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKbeta-mTORC1 axis to regulate renal cancer cell invasion. Exp Cell Res. 328:99–117. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hildebrandt MA, Gu J, Lin J, et al: Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene. 29:5724–5728. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gebauer K, Peters I, Dubrowinskaja N, et al: Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma. Br J Cancer. 108:131–138. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Beresneva EV, Rykov SV, Hodyrev DS, et al: Methylation profile of group of miRNA genes in clear cell renal cell carcinoma; involvement in cancer progression. Genetika. 49:366–375. 2013.PubMed/NCBI | |
|
Creighton CJ, Morgan M, Gunaratne PH, et al: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 499:43–49. 2013. View Article : Google Scholar | |
|
Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG and Wu X: Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 31:1805–1812. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hell MP, Thoma CR, Fankhauser N, Christinat Y, Weber TC and Krek W: miR-28-5p promotes chromosomal instability in VHL-associated cancers by inhibiting Mad2 translation. Cancer Res. 74:2432–2443. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Prior C, Perez-Gracia JL, Garcia-Donas J, et al: Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma. PLoS One. 9:e862632014. View Article : Google Scholar : PubMed/NCBI | |
|
Powers MP, Alvarez K, Kim HJ and Monzon FA: Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping. Diagn Mol Pathol. 20:63–70. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zaravinos A, Lambrou GI, Mourmouras N, et al: New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney. PLoS One. 9:e916462014. View Article : Google Scholar : PubMed/NCBI | |
|
Youssef YM, White NM, Grigull J, et al: Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol. 59:721–730. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wulfken LM, Moritz R, Ohlmann C, et al: MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One. 6:e257872011. View Article : Google Scholar : PubMed/NCBI | |
|
Iwamoto H, Kanda Y, Sejima T, Osaki M, Okada F and Takenaka A: Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma. Int J Oncol. 44:53–58. 2014. | |
|
Zhao A, Li G, Peoc’h M, Genin C and Gigante M: Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol. 94:115–120. 2013. View Article : Google Scholar | |
|
Von Brandenstein M, Pandarakalam JJ, Kroon L, et al: MicroRNA 15a, inversely correlated to PKCalpha, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. Am J Pathol. 180:1787–1797. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, Zhao H, Lu Y, Li H and Yan G: MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma. Tumour Biol. Aug 6–2014.(Epub ahead of print). View Article : Google Scholar | |
|
Shinmei S, Sakamoto N, Goto K, et al: MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma. Int J Urol. 20:468–477. 2013. View Article : Google Scholar | |
|
Slaby O, Redova M, Poprach A, et al: Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer. 51:707–716. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang G, Chen L, Meng J, Chen M, Zhuang L and Zhang L: Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma. Int Urol Nephrol. 45:373–379. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao JJ, Chen PJ, Duan RQ, Li KJ, Wang YZ and Li Y: Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival. Int J Clin Exp Pathol. 7:3318–3323. 2014.PubMed/NCBI | |
|
Wu X, Weng L, Li X, et al: Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI | |
|
Slaby O, Jancovicova J, Lakomy R, et al: Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res. 29:902010. View Article : Google Scholar : PubMed/NCBI | |
|
Berkers J, Govaere O, Wolter P, et al: A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistance. J Urol. 189:1930–1938. 2013. View Article : Google Scholar | |
|
Chen B, Duan L, Yin G, Tan J and Jiang X: Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells - Cdc2 activity is up-regulated by targeting WEE1. Clinics. 68:825–833. 2013. View Article : Google Scholar | |
|
Yu G, Li H, Wang J, et al: miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells. J Urol. May 24–2014.(Epub ahead of print). View Article : Google Scholar | |
|
Redova M, Poprach A, Besse A, et al: MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol. 34:481–491. 2013. View Article : Google Scholar | |
|
Schiffgen M, Schmidt DH, von Rucker A, Muller SC and Ellinger J: Epigenetic regulation of microRNA expression in renal cell carcinoma. Biochem Biophys Res Commun. 436:79–84. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen B, Duan L, Yin G, Tan J and Jiang X: miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O. J Chemother. 25:229–238. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, He J, Su F, et al: Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition. Cell Death Dis. 4:e6992013. View Article : Google Scholar : PubMed/NCBI |
